CERVICAL ADENOSQUAMOUS CARCINOMA

Clinical trials for CERVICAL ADENOSQUAMOUS CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new CERVICAL ADENOSQUAMOUS CARCINOMA trials appear

Sign up with your email to follow new studies for CERVICAL ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 5 Completed 1

Experimental cancer drug enters first human trials for Tough-to-Treat tumors

Disease control Recruiting now

This is the first study in humans testing a new cancer drug called AVA6103. The trial aims to find a safe dose and see if the drug shows early signs of helping patients with advanced solid tumors that have spread or cannot be removed by surgery. It will enroll adults with specifi…

Matched conditions: CERVICAL ADENOSQUAMOUS CARCINOMA

Phase: PHASE1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

CERVICAL ADENOSQUAMOUS CARCINOMA

Get alerted when new CERVICAL ADENOSQUAMOUS CARCINOMA trials appear

Experimental cancer drug enters first human trials for Tough-to-Treat tumors